Even though the World Health Organization has published the largest randomized trial showing that remdesivir showed no benefit on reducing hospital stays or mortality, the drug has been approved by the U.S. FDA for standard of care use for hospitalized COVID-19 patients. The approval was based on a study by …
Read More »
Medicosnext